Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 653048 in healthy male volunteers
NCT02217644Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2008
- Primary completion
- Jun 2009
01
Overview
Phase 1, randomised, single-blind trial of BI 653048 in rheumatoid arthritis (RA), sponsored by Boehringer Ingelheim. Started Nov 2008; status: completed.
02
Drugs
BI 653048
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02217644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02217644.